- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: B-cell antigens
Total 2747 results
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGNot yet recruiting
-
Huazhong University of Science and TechnologyRecruitingDiffuse Large B Cell LymphomaChina
-
Juventas Cell Therapy Ltd.Not yet recruiting
-
Massachusetts General HospitalVarian Medical SystemsRecruitingLymphoma, B-Cell | Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Lymphoma | High-grade B-cell Lymphoma | Relapsed Cancer | Mediastinal Large B-cell LymphomaUnited States
-
Uppsala UniversityKarolinska University Hospital; Uppsala University Hospital; Elicera TherapeuticsRecruiting
-
Beijing HospitalChanghai Hospital; Xiangya Hospital of Central South University; Peking University... and other collaboratorsNot yet recruitingConnective Tissue Diseases | ThrombocytopeniaChina
-
Shenzhen Geno-Immune Medical InstituteThe Second Affiliated Hospital of Hainan Medical University; Beijing Jingdu...Recruiting
-
The First Hospital of Jilin UniversityCSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
University of BirminghamRegeneron Pharmaceuticals; Cancer Research UK; Fight Kids Cancer; ADC Therapeutics...Not yet recruiting
-
Medical College of WisconsinNot yet recruitingFollicular Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma
-
Central Hospital, Nancy, FranceNot yet recruitingAntisynthetase SyndromeFrance
-
Fundación Pública Andaluza para la gestión de la...Not yet recruitingMultiple Myeloma | Allogeneic Stem Cell TransplantationSpain
-
CARGO TherapeuticsRecruitingCancer | Relapsed/Refractory Large B-cell Lymphoma (LBCL)United States
-
National Cancer Institute (NCI)RecruitingAcute Lymphoblastic Leukemia | Relapsed/Refractory | B CellUnited States
-
National Cancer Institute (NCI)RecruitingMesothelioma | BRCA1-Associated Protein-1 (BAP1) Mutations | Malignant Mesothelioma (MM) | Early-stage Mesothelioma | Subclinical Mesothelioma | Early-stage BAP1-associated MalignanciesUnited States
-
University Health Network, TorontoTakara Bio Inc.RecruitingRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma | Relapsed or Refractory CD19+ B-cell LymphomaCanada
-
AstraZenecaHospital Israelita Albert EinsteinRecruitingDiffuse Large B Cell LymphomaBrazil
-
Regeneron PharmaceuticalsRecruiting
-
Hoffmann-La RocheRecruiting
-
AstraZenecaNot yet recruitingDiffuse Large B-Cell Lymphoma
-
Fate TherapeuticsRecruitingRelapsed/Refractory B-Cell LymphomaUnited States
-
University Health Network, TorontoRecruitingDLBCL - Diffuse Large B Cell LymphomaCanada
-
Peng LiuRecruitingDiffuse Large B Cell LymphomaChina
-
Peng LiuRecruitingDiffuse Large B Cell LymphomaChina
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma | Large-cell Lymphoma | Mediastinal B-Cell Diffuse Large Cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; American Society of Clinical Oncology; Applebaum FoundationRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell LymphomaUnited States
-
Fred Hutchinson Cancer CenterFaron Pharmaceuticals LtdNot yet recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Mantle Cell LymphomaUnited States
-
Jennifer Crombie, MDMerck Sharp & Dohme LLCRecruitingPrimary Mediastinal Large B-cell Lymphoma (PMBCL) | Primary Mediastinal Large B Cell Lymphoma | T-Cell/Histiocyte-Rich Large B-Cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma Refractory | Primary Mediastinal Large B-Cell Lymphoma Recurrent | Epstein-Barr Virus Positive Diffuse Large...United States
-
920th Hospital of Joint Logistics Support Force...RecruitingB-Cell Leukemia | B-Cell Lymphoma | B-cell TumorsChina
-
Fondazione Italiana Linfomi - ETSNot yet recruitingClassical Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma (DLBCL)Italy
-
Shandong Cancer Hospital and InstituteThe First Affiliated Hospital of Nanchang UniversityRecruitingThe First Affiliated Hospital of Nanchang UniversityChina
-
Ruijin HospitalRecruiting
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingRefractory Lymphoma | Relapse | B-cell Non Hodgkin LymphomaItaly
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, DiffuseChina
-
Ruijin HospitalNot yet recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Richter Syndrome | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingGlioblastoma Multiforme
-
Yonsei UniversitydotterRecruitingCoronary Artery Disease | DyslipidemiasKorea, Republic of
-
IDP Discovery Pharma S.L.RecruitingChronic Lymphocytic Leukemia (CLL) | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Multiple Myeloma (MM) | High Grade B-Cell Lymphoma, Not Otherwise Specified | Double Hit Lymphoma | Triple Hit LymphomaSpain
-
Xiangyang No.1 People's HospitalQingdao Haier Biotechnology Co.,Ltd.Not yet recruitingB-cell Lymphoma Refractory | B-cell Lymphoma Recurrent | NK CellChina
-
National Cancer Institute (NCI)RecruitingLymphoma, Primary EffusionUnited States
-
Ruijin HospitalThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaboratorsNot yet recruitingLymphoma | Marginal Zone Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa-Associated Lymphoid Tissue Lymphoma | Intravascular Large B-Cell Lymphoma | Extranodal Lymphoma | NK/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
National Cancer Institute (NCI)RecruitingNeoplasms | Esophageal Neoplasms | Esophagus Cancer | Esophagus Neoplasm | Neoplasms, Esophageal | Esophageal Cancer (EsC)United States
-
PfizerHoffmann-La RocheRecruitingDiffuse Large B-Cell LymphomaUnited States, Taiwan, Japan, Israel
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGeneRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
University of Milano BicoccaRecruitingMantle-cell Lymphoma | B Cell Chronic Lymphocytic LeukemiaItaly
-
Liaoning Tumor Hospital & InstituteNot yet recruitingDiffuse Large B Cell LymphomaChina
-
Joshua Sasine, MD, PhDRecruitingMultiple Myeloma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Hematologic Malignancy | Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsRecruitingPrimary Immune Thrombocytopenia (ITP)Spain, Italy, France, Germany, China, Korea, Republic of, Czechia, Turkey, Malaysia, United States, Argentina, Australia, United Kingdom, Poland
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
Zhao WeiliNot yet recruitingDiffuse Large B-cell LymphomaChina